Dara Wright's most recent trade in Bio-Rad Laboratories Inc. - Ordinary Shares - Class A was a trade of 502 Bio-Rad A Common Stock done . Disclosure was reported to the exchange on Dec. 16, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bio-Rad Laboratories Inc. ... | Dara Grantham Wright | EVP, President, CDG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2023 | 502 | 2,001 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Wright Dara Grantham | EVP, President, CDG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2023 | 502 | 503 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Grantham Wright Dara | EVP, President, CDG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 306.12 per share. | 16 Dec 2023 | 174 | 1,827 (0%) | 0% | 306.1 | 53,265 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Dara Wright Grantham | EVP, President, CDG | Sale of securities on an exchange or to another person at price $ 299.16 per share. | 12 Dec 2023 | 1,200 | 1,499 (0%) | 0% | 299.2 | 358,992 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Dara Grantham Wright | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2023 | 3,005 | 3,005 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Dara Grantham Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 520 | 2,314 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Dara Grantham Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 520 | 1,562 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Dara Grantham Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 433 | 2,831 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Dara Grantham Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 433 | 434 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Dara Grantham Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 405 | 2,539 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Dara Grantham Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 405 | 811 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Dara Grantham Wright | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 180 | 2,134 (0%) | 0% | 394.6 | 71,028 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Dara Grantham Wright | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 150 | 2,681 (0%) | 0% | 394.6 | 59,190 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Dara Grantham Wright | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 141 | 2,398 (0%) | 0% | 394.6 | 55,639 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Dara Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2022 | 502 | 1,987 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Dara Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2022 | 502 | 1,005 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Dara Wright | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 407.98 per share. | 16 Dec 2022 | 226 | 1,761 (0%) | 0% | 408.0 | 92,203 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Dara Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 433 | 1,609 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Dara Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 433 | 867 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Dara Wright | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 150 | 1,459 (0%) | 0% | 478.3 | 71,748 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Dara Wright | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 2,082 | 2,082 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Dara Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 405 | 1,317 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Dara Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 405 | 1,216 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Dara Wright | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 486.25 per share. | 01 Sep 2022 | 141 | 1,176 (0%) | 0% | 486.2 | 68,561 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Dara Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2021 | 502 | 1,113 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Dara Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2021 | 502 | 1,507 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Dara Wright | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 734.34 per share. | 16 Dec 2021 | 221 | 892 (0%) | 0% | 734.3 | 162,289 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Dara Wright | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 1,621 | 1,621 | - | - | Non-Qualified Stock Option (right to buy) | |
| Bio-Rad Laboratories Inc. ... | Dara Wright | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 1,621 | 1,621 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Dara Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 433 | 761 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Dara Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 433 | 1,300 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Dara Wright | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 825.77 per share. | 01 Sep 2021 | 150 | 611 (0%) | 0% | 825.8 | 123,866 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Dara Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2020 | 502 | 502 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Dara Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2020 | 502 | 2,009 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Dara Wright | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 576.72 per share. | 16 Dec 2020 | 174 | 328 (0%) | 0% | 576.7 | 100,349 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Dara Wright | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2020 | 1,733 | 1,733 | - | - | Non-Qualified Stock Option (right to buy) | |
| Bio-Rad Laboratories Inc. ... | Dara Wright | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2020 | 1,733 | 1,733 | - | - | Restricted Stock Units |